Advisors Asset Management, Inc. Astrazeneca PLC Transaction History
Advisors Asset Management, Inc.
- $5.62 Billion
- Q3 2025
A detailed history of Advisors Asset Management, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 50,365 shares of AZN stock, worth $4.5 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
50,365
Previous 41,912
20.17%
Holding current value
$4.5 Million
Previous $2.93 Million
31.97%
% of portfolio
0.07%
Previous 0.05%
Shares
33 transactions
Others Institutions Holding AZN
# of Institutions
1,536Shares Held
502MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...